Yan Zhao

Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441

Yan Zhao, Huw D. Thomas, Michael A. Batey et al. · Cancer Research · 2006 · 447 citations · Full text

Medicine, Oncology, Pharmacology +16

Involvement of MAPK/NF-κB Signaling in the Activation of the Cholinergic Anti-Inflammatory Pathway in Experimental Colitis by Chronic Vagus Nerve Stimulation

Peng Sun, Kewen Zhou, Sheng Wang et al. · PLoS ONE · 2013 · 207 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, <i>In Vitro</i> and <i>In Vivo</i> in p53 Functional and Dysfunctional Models of Human Cancer

Michael A. Batey, Yan Zhao, Suzanne Kyle et al. · Molecular Cancer Therapeutics · 2013 · 158 citations · Full text

Medicine, Oncology, Pharmacology +17

Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K

Joanne M. Munck, Michael A. Batey, Yan Zhao et al. · Molecular Cancer Therapeutics · 2012 · 131 citations · Full text

Medicine, Oncology, Pharmacology +11

Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription

Weiwei Yang, Jing Li, Minghui Zhang et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 73 citations · Full text

Medicine, Molecular Biology, Oncology +17